During ASMS 2024, which will take place June 2–6, 2024 in Anaheim, California, many scientists are set to present research on the latest advances in mass spectrometry. Recently, LCGC International sat down with Elizabeth Neumann of the University of California, Davis to discuss her presentation, "Multi-Site Reproducibility Trial of MALDI-IHC Multiplexed Targeted Protein Imaging using a 33-Organ Tissue Microarray."
Elizabeth Neumann is an Assistant Professor in the Department of Chemistry at the University of California, Davis. She has been a NIH Postdoctoral Fellow at Vanderbilt University, a NSF Doctoral Fellow at University of Illinois at Urbana-Champaign, and she has earned a BS in Chemistry from Baylor University (1). Her lab joined the UC Davis Chemistry Department in the summer of 2022 and focuses on understanding the molecular and cellular architecture behind neurological diseases. The research is highly interdisciplinary and involves developing analytical tools and multimodal imaging methods for understanding complex biological phenomena.
In this interview, Neumann answers the following questions:
To see more about what ASMS 2024 will have in store, see our interviews with Peter Horvatovich of the University of Groningen and Nick Riley of the University of Washington.
(1) Elizabeth Neumann. The Regents of the University of California, Davis campus 2022. https://chemistry.ucdavis.edu/people/elizabeth-neumann (accessed 2024-5-28)
In Conversation with the EAS Award Winner for Outstanding Achievements in Mass Spectrometry
November 27th 2024As part of our EAS 2024 coverage, we recently interviewed Benjamin Garcia of the Washington University in St. Louis about his work and his being awarded the EAS Award for Outstanding Achievements in Mass Spectrometry.
Inside the Laboratory: The Zydney Group at Pennsylvania State University
November 26th 2024In this edition of “Inside the Laboratory,” Andrew Zydney of Pennsylvania State University discusses his laboratory’s work with using high performance liquid chromatography (HPLC) to analyze biopharmaceutical products before and after membrane separation processes.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.